Lipocine Inc.

LPCN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$0-$16-$11-$1
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$1
Change in WC-$1$2-$1-$5
Other Non-Cash-$1$2-$1$0
Operating Cash Flow-$1-$12-$12-$4
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0-$14$43,780
Inv. Purchases-$33-$23-$45-$48
Inv. Sales/Matur.$35$36$60$5
Other Inv. Act.$0$0$14-$43,780
Investing Cash Flow$2$13$14-$44
Financing Activities
Debt Repay.$0$0-$2-$3
Stock Issued$0$0$0$30
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0-$2$27
Forex Effect$0$0$0$0
Net Chg. in Cash$1$2$0-$21
Supplemental Information
Beg. Cash$5$3$3$24
End Cash$6$5$3$3
Free Cash Flow-$1-$12-$12-$4
Lipocine Inc. (LPCN) Financial Statements & Key Stats | AlphaPilot